INDV - Indivior PLC Ordinary Shares -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Indivior PLC Ordinary Shares
IPO Date: June 12, 2023
Sector: Healthcare
Industry: Drug Manufacturers
Market Cap: $4.12B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.43 | 2.14%
Avg Daily Range (30 D): $0.42 | 1.14%
Avg Daily Range (90 D): $0.65 | 1.72%
Institutional Daily Volume
Avg Daily Volume: .93M
Avg Daily Volume (30 D): 1.51M
Avg Daily Volume (90 D): 1.5M
Trade Size
Avg Trade Size (Sh.): 82
Avg Trade Size (Sh.) (30 D): 75
Avg Trade Size (Sh.) (90 D): 72
Institutional Trades
Total Institutional Trades: 1,894
Avg Institutional Trade: $4.91M
Avg Institutional Trade (30 D): $5.11M
Avg Institutional Trade (90 D): $4.94M
Avg Institutional Trade Volume: .2M
Avg Institutional Trades (Per Day): 3
Market Closing Trades
Avg Closing Trade: $10.05M
Avg Closing Trade (30 D): $12.05M
Avg Closing Trade (90 D): $12.89M
Avg Closing Volume: 348.92K
 
News
Sep 2, 2026 @ 3:30 PM
Indivior Pharmaceuticals Inc. (INDV) Down 5.3% Sin...
Source: Zacks.Com
Aug 3, 2026 @ 10:05 PM
Why Supernus Pharmaceuticals Stock Topped the Mark...
Source: Eric Volkman
Jul 23, 2026 @ 2:00 PM
Indivior to Report Second Quarter 2026 Financial R...
Source: Na
Jun 2, 2026 @ 11:00 AM
Herantis reports positive FDA feedback and finaliz...
Source: Herantis Pharma Plc
May 30, 2026 @ 8:01 PM
What to Know About This Fund's $74.8 Million Indiv...
Source: Jonathan Ponciano
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $2.88 $1.02 $.71
Diluted EPS $2.79 $.98 $.69
Revenue $1.33B $343M $317M
Gross Profit $1.09B $294M $276M
Net Income / Loss $355M $122M $89M
Operating Income / Loss $421M $160M $137M
Cost of Revenue $240M $50M $40M
Net Cash Flow $-285M
PE Ratio